UCB execs take positive stance as big pharma peers wail about difficult environment
This article was originally published in Scrip
Executive Summary
In a week in which big pharma executives Dr Marijn Dekkers of Bayer and GlaxoSmithKline's Sir Andrew Witty have drawn the limelight with their laments about the difficult environment and lack of general appreciation for the industry, executives at Belgian group UCB struck a more positive tone at their annual results meeting on Friday.